NATALEE Adj Ribociclib
Final iDFS Analysis of NATALEE: Phase III Trial of Adjuvant Ribociclib + Nonsteroidal Aromatase Inhibitor in HR+/HER2- EBC

Released: December 10, 2023

Activity

Progress
1
Course Completed